Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Hemostatic Clinical Trial

Official title:
"A Physician-initiated, Observational, Prospective, Monocentric Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair "- PuraBond Study

Status Recruiting

Clinical Trial Summary

Purabond Study is a physician-initiated, observational, monocentric prospective Trial. The aim of the study is to investigate the hemostatic efficacy of PuraBond for aortic anastomoses and suture lines in patients with abdominal aortic pathology (aneurysmal or steno occlusive disease) candidate to open repair at Vascular Surgery Departement - San Raffaele Hospital (Milan, Italy). The Study will include 100 patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hemostatic

Clinical Trial Details

NCT number	NCT05733585
Study type	Observational
Source	IRCCS San Raffaele
Contact	Daniele Mascia, MD
Phone	+390226437141
Email	mascia.daniele@hsr.it
Status	Recruiting
Phase
Start date	February 15, 2023
Completion date	October 31, 2024

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06451185` - Statseal® for Central Venous Catheter Insertion Sites in Critical Care	N/A
	Completed	`NCT02972684` - Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary Bypass	N/A